ID
24291
Description
Study ID: 100468 Clinical Study ID: AVA100468 Study Title: An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia XR,Avandia; Avandia XR,Rosiglitazone XR,Avandia Study Indication: Alzheimer's Disease Study Conclusion
Keywords
Versions (1)
- 7/28/17 7/28/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
July 28, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC-ND 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Study Conclusion GSK Rosiglitazone Alzheimer's disease 100468
Study Conclusion GSK Rosiglitazone Alzheimer's disease 100468
- StudyEvent: ODM
Description
Pregnancy Information
Alias
- UMLS CUI-1
- C0032961 (Pregnancy)
- SNOMED
- 289908002
- LOINC
- LP75920-6
Description
Study Conclusion
Alias
- UMLS CUI-1
- C1707478 (Conclusion)
Description
Completion, Withdrawal
Data type
date
Measurement units
- dd-mmm-yy
Alias
- UMLS CUI [1]
- C0805732 (Completion Status)
- UMLS CUI [2]
- C2349954 (Withdraw (activity))
Description
* If YES, specify the primary reason.
Data type
text
Alias
- UMLS CUI [1]
- C2349954 (Withdraw (activity))
Description
Primary Reason of Withdrawal
Data type
text
Alias
- UMLS CUI [1,1]
- C2349954 (Withdraw (activity))
- UMLS CUI [1,2]
- C1549995 (Primary Reason)
Description
Primary Reason of Withdrawal Specification
Data type
text
Alias
- UMLS CUI [1,1]
- C2349954 (Withdraw (activity))
- UMLS CUI [1,2]
- C1549995 (Primary Reason)
- UMLS CUI [1,3]
- C2348235 (Specification)
Description
Investigator's Signature
Alias
- UMLS CUI-1
- C2346576 (Investigator Signature)
Description
Investigature's name
Data type
text
Alias
- UMLS CUI [1]
- C2346576 (Investigator Signature)
Description
Date of Report
Data type
date
Measurement units
- dd-mmm-yy
Alias
- UMLS CUI [1]
- C1302584 (Date of report)
- SNOMED
- 399651003
Similar models
Study Conclusion GSK Rosiglitazone Alzheimer's disease 100468
- StudyEvent: ODM
C2349954 (UMLS CUI [2])
C1549995 (UMLS CUI [1,2])
C1549995 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
No comments